Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer

0
12
Stereotactic ablative radiotherapy induces anti-tumor immunity in clinical and preclinical studies, but immunological biomarkers are lacking.
[Clinical Cancer Research]
Abstract